Invesco (IVZ) is a publicly traded Financial Services sector company. As of July 5, 2026, IVZ trades at $27.01 with a market cap of $11.97B and a P/E ratio of -18.37. IVZ moved +0.67% today. Year to date, IVZ is +2.08%; over the trailing twelve months it is +62.81%. Its 52-week range spans $11.60 to $29.82. Analyst consensus is buy with an average price target of $28.94. Rallies surfaces IVZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
State Street Health Care ETF Outpaces Invesco Pharma ETF on Cost and Scale: State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and manages far more assets than the Invesco Pharmaceuticals ETF. Invesco’s fund holds 29 pharmaceutical companies, while the SPDR fund provides broader exposure across the entire healthcare sector.
| Metric | Value |
|---|---|
| Price | $27.01 |
| Market Cap | $11.97B |
| P/E Ratio | -18.37 |
| EPS | $-1.47 |
| Dividend Yield | 0.21% |
| 52-Week High | $29.82 |
| 52-Week Low | $11.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.59B |
| Net Income | $-223.00M |
| Gross Margin | 0.00% |
10 analysts cover IVZ: 0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.94.